M (continued)
- MET tyrosine kinase inhibitor EMD 1214063
- MET tyrosine kinase inhibitor PF-02341066
- MET tyrosine kinase inhibitor PF-04217903
- MET/VEGFR-2 inhibitor GSK1363089
- metabolic
- metabolic acidosis
- metabolic disorder
- metabolic syndrome
- metabolic syndrome X
- metabolic therapy
- metabolic type
- metabolism
- metabolite
- metallic
- metaplasia
- metaplastic carcinoma
- metastasectomy
- metastasis
- metastasize
- Metastat
M (continued)
- metastatic
- Metastron
- metasynchronous
- meteorism
- metformin
- metformin hydrochloride
- methadone hydrochloride
- Methadose
- methanol extraction residue of BCG
- methazolamide
- Methazolastone
- methemoglobin
- methemoglobinemia
- methionine C 11
- methodology
- Methosarb
- methotrexate
- Methotrexate LPF
- methotrexate-e therapeutic implant
- methoxsalen